Tuesday, November 29, 2022: M&A

Boston Scientific announced it entered a definitive agreement to acquire Apollo Endosurgery for a cash price of $10 per share to reflect an enterprise value of approximately $615 million. Apollo Endosurgery anticipates net sales of approximately $76 million in the...